Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Gift Director gave 3,564 shares (gift)
  6. 4 Option exercise Director acquired 3,388 shares (option exercise)
  7. 4 Option exercise Director acquired 3,388 shares (option exercise)
  8. 4 Option exercise Director acquired 3,388 shares (option exercise)
  9. 4 Option exercise Director acquired 3,388 shares (option exercise)
  10. 4 Option exercise Director acquired 3,388 shares (option exercise)
  11. 4 Option exercise Director acquired 3,388 shares (option exercise)
  12. 4 Option exercise Director acquired 1,976 shares (option exercise)
  13. 4 Option exercise Director acquired 1,976 shares (option exercise)
  14. 4 Planned sale Chief Executive Officer sold 12,115 shares at $48.84 ($591,697)
  15. 4 Open-market sale Principal Accounting Officer sold 1,362 shares at $44.39 ($60,459)
  16. 4 Planned sale Director sold 7,791 shares at $27.55 ($214,642)
  17. 4 Open-market sale Director sold 1,285 shares at $31.62 ($40,632)
  18. 4 Open-market sale Director sold 4,715 shares at an average $32.00 ($150,899)
  19. 4 Open-market sale Principal Accounting Officer sold 1,913 shares at $31.75 ($60,738)
  20. 4 Planned sale Chief Medical Officer sold 2,642 shares at $32.57 ($86,050)

Page 6 of 38 · 758 filings